Insulrap

Insulrap: short-acting, long-lasting relief

Insulin is a hormone that is necessary for the normal functioning of the body, namely to control blood sugar levels. When the body does not produce enough insulin or does not use it effectively, diabetes may develop. Diabetes is a dangerous disease that requires constant monitoring and care, including with the help of medications.

One of these drugs is Insulrap, produced by Pliva (Croatia). This drug belongs to the group of short-acting insulins. It is used to control blood glucose levels in patients with diabetes.

Insulrap is an injection solution with a concentration of 40 U/ml. It contains insulin-BD, which is the international name for this drug. In addition, Insulrap has several synonyms, including Berlinsulin N Normal U-40, Berlinsulin N Normal pen, Biogulin Regular U-100, Biogulin Regular U-40, Biosulin N, Brinsulrapi MK, Brinsulrapi H, Insulin, Insulin "M", Insulin Actrapid, Insulin Actrapid MK, Insulin Actrapid MS, Insulin Iletin II Regular.

Insulrap is produced in the form of a solution for injection and subcutaneous administration. It is usually injected into the thigh, abdomen, or shoulder, only under the supervision of a doctor or other health care professional. The dosage of Insulrap should be individualized and depends on the level of glucose in the blood and other factors such as age, weight, lifestyle and health of the patient.

Insulrap allows you to control blood glucose levels for 4-8 hours after administration and can be used as a single dose or in combination with other medications for the treatment of diabetes, including long-acting insulins.

In conclusion, Insulrap is an effective drug for controlling blood glucose levels in patients with diabetes. It is produced by Pliva in Croatia and has several synonyms. The dosage of Insulrap should be individual and prescribed only by a medical specialist.